8 A novel antibacterial acellular porcine dermal matrix cross-linked with oxidized chitosan oligosaccharide and modified by in situ synthesis of silver nanoparticles for wound healing applications

9 Exploring the cytotoxicity, uptake, cellular response, and proteomics of mono- and dinuclear DNA light-switch complexes.

10 Raman tweezers microspectroscopy of circa 100 nm extracellular vesicles.

11 Measurement of calcium buffering by intracellular organelles in brain.

12 MeIQx alters autophagosome maturation, cellular lipidomic profiles and expression of core pluripotent factors.

13 3D Construction of Shape-Controllable Tissues through Self-Bonding of Multicellular Microcapsules.

14 Extracellular vesicle-mediated macrophage activation: An insight into the mechanism of thioredoxin-mediated immune activation.

15 Intracellular hyaluronan: Importance for cellular functions.

16 The natural product antroalbol H promotes phosphorylation of liver kinase B1 (LKB1) at threonine 189 and thereby enhances cellular glucose uptake.

17 Intracellular dark-field imaging of ATP and photothermal therapy using a colorimetric assay based on gold nanoparticle aggregation via tetrazine/trans-cyclooctene cycloaddition.

18 A Liposomal Platform for Sensing of Extracellular Analytes Near Cells.

19 Poly-l-lysine-coated magnetic nanoparticles as intracellular actuators for neural guidance

20 Evaluation of extracellular polymeric substances extracted from waste activated sludge as a renewable corrosion inhibitor.

21 Protective Effect of Carvacrol on Oxidative Stress and Cellular DNA Damage Induced by UVB Irradiation in Human Peripheral Lymphocytes.

22 Prognostic profile of patients with non-viral hepatocellular carcinoma: A comparative study with hepatitis C virus-related hepatocellular carcinoma using data mining analysis.

23 Reversible Click Chemistry for Ultrafast and Quantitative Formation of Protein-Polymer Nanoassembly and Intracellular Protein Delivery.

24 Estrogen receptor-mediated targeting of the extracellular matrix network in cancer.

25 Functional Estrogen Receptors of Red Blood Cells. Do They Influence Intracellular Signaling?

26 Targeting hepatocellular carcinoma: Synthesis of new pyrazole-based derivatives, biological evaluation, DNA binding, and molecular modeling studies

27 Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage

28 Association of CTLA-4 tagging polymorphisms and haplotypes with hepatocellular carcinoma risk: A case-control study.

29 Quantitative proteomics identify an association between extracellular matrix degradation and immunopathology of genotype VII Newcastle disease virus in the spleen in chickens.

30 iGPCR-drug: a web server for predicting interaction between GPCRs and drugs in cellular networking.

31 Bacterial Extracellular Polysaccharides Involved in Biofilm Formation

32 Extracellular MatrixâAssociated Factors Play Critical Roles in Regulating Pancreatic Î²-Cell Proliferation and Survival

33 Ankaferd Blood Stopper with antibiofilm potential successfully inhibits the extracellular matrix degradation enzymes and promotes wound healing of 3T3 fibroblasts in vitro

34 Silver-pig skin nanocomposites and mesenchymal stem cells: Suitable antibiofilm cellular dressings for wound healing

35 Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial

36 Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma

37 Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma

38 Intermediate stage hepatocellular carcinoma: a summary review

39 Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve

40 Post-translational modifiers of liver kinase B1/serine/threonine kinase 11 in hepatocellular carcinoma

41 Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives

42 Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date

43 Weighing the benefits of hepatocellular carcinoma surveillance against potential harms

44 Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions

45 Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria

46 Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist

47 Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein

48 Update on hepatocellular carcinoma from the 2018 Gastrointestinal Cancer Symposium (ASCO GI)

49 Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancer

50 Hepatocellular cancer pain: impact and management challenges

51 Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance

52 Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance

53 Editorial: charting the future of hepatocellular carcinoma publications

54 Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt

55 Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma

56 Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma

57 Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma

58 Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions

59 Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma

60 Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review

61 Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies

62 Hepatocellular carcinoma: early-stage management challenges

63 Screening for hepatocellular carcinoma: patient selection and perspectives

64 Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

65 Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives

66 A single institution report of 19 hepatocellular carcinoma patients with bile duct tumor thrombus

67 Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge

68 Pediatric hepatocellular carcinoma: challenges and solutions

69 Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients

70 Surgical resection of localized hepatocellular carcinoma: patient selection and special consideration

71 Profile of tivantinib and its potential in the treatment of hepatocellular carcinoma: the evidence to date

72 GPC-3 in hepatocellular carcinoma: current perspectives

73 Minimally invasive image-guided therapies for hepatocellular carcinoma

74 Hepatocellular carcinoma: a review

75 Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary

76 Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma

77 Transarterial radioembolization for hepatocellular carcinoma: a review

78 Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients

79 Hepatocellular carcinoma in elderly patients: challenges and solutions

80 Fibrolamellar hepatocellular carcinoma: current clinical perspectives

81 Role of endoscopic ultrasound in diagnosis and management of hepatocellular carcinoma

82 Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma

83 Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy

84 Whither α-FP in the diagnosis of hepatocellular carcinoma?

85 The androgen receptor as an emerging target in hepatocellular carcinoma

86 Emerging role of Hpo signaling and YAP in hepatocellular carcinoma

87 Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy

88 Hepatocellular carcinoma ablation and possible immunity in the age of nanosecond pulsed electric fields

89 Early α-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib

90 c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma

91 A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma

92 Emerging role of Toll-like receptor 4 in hepatocellular carcinoma

93 Untreated hepatocellular carcinoma in Egypt: outcome and prognostic factors

94 Welcome to Journal of Hepatocellular Carcinoma

95 Chemoembolization with drug-eluting microspheres (DEM-TACE) for hepatocellular carcinoma: single-center review of safety and efficacy

96 Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

97 Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments

98 Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models

99 Radiological diagnosis of hepatocellular carcinoma

100 Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma

101 Hepatocellular carcinoma: epidemiology and risk factors

Keyword Connections

Journals

Research Groups

Bibliographies